报告题目：Global effort to control HIV epidemic and prevent new HIV infections.
报 告 人：杨春富 研究员
Chun fu Yang obtained her DVM from NEAG in 1982 and Master degree from Beijing Agriculture University in 1985 and PhD in 1992 from University of Maine.
She started her postdoctoral training after graduating from U Maine at US CDC and later became a federal employee. Currently she is the Team Lead of Molecular Diagnostics and Surveillance Team at the International Lab Branch, Division of Global HIV and TB, Center for Global Health, US Centers for Disease Control and Prevention (CDC). She is the members of WHO HIV Drug Resistance Network (Res Net) Steering Committees and Lab Director of WHO-designated Specialized Drug Resistance Laboratory (SDRL), the only one in US.
Her research focuses on development of resources limited settings-friendly molecular assays for supporting PEPFAR programs on improving care and treatment, and Prevention programs. She holds two patents. The low cost and broadly sensitive HIV Drug-Resistance genotyping assay developed by her team is manufactured by a US-based biotech company and is being used by many PEPFAR-SUPPORTED countries for assessment and Prevention of HIV Drug Resistance surveillance programs. She has published over 90 peer reviewed articles, book chapters and web-based publications. She is the leading authority on HIV Drug Resistance and viral load testing using dried blood spots. Some of her research results were published in highly regarded infectious disease journals, such as Clinical Infectious Diseases which has the 2nd highest impact factors (>15). Some of her publications have been highly cited by her peers. Her research results were the main bases of WHO 2014 updated strategy on HIV Drug-Resistance assessment and Prevention using dried blood spots. Her team is supporting over 40 countries on technical needs and laboratory capacity building on HIV drug resistance and has about 1.5 million dollars budget per year.